12,841 resources
Start Prev Rows 600 - 800 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Auth | Source(s) |
---|---|---|---|---|---|---|---|---|---|
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.515 | Bariatric Procedures | active | 2024-02 | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.517 | Age related macular degeneration intermediate dry | active | 2024-06 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.518 | Ophthalmologist visit | active | 2024-06 | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.519 | Posterior vitreous detachment (PVD) | active | 2024-06 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.521 | Ophthalmoscopic exam | active | 2024-06 | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.523 | Opthalmoscopic exams with Scleral Depression | active | 2024-06 | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.525 | Referral (ophthalmology) | active | 2024-06 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.526 | Retina Ultrasound | active | 2024-06 | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.527 | Retina visualization inadequate | active | 2024-06 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.528 | Refusal or Noncompliance with treatment | active | 2024-06 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.529 | Vitreous hemorrhage | active | 2024-06 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.530 | Vitreous hemorrhage | active | 2024-06 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.536 | Macula examination | active | 2024-06 | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.539 | Fluorescein angiography | active | 2024-06 | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.541 | Optical coherence tomography (OCT) | active | 2024-06 | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.542 | Intravitreal injection | active | 2024-06 | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.543 | Bevacizumab injection | active | 2024-06 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.544 | Ranibizumab injection | active | 2024-06 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.545 | Aflibercept injection | active | 2024-06 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.552 | Uveitis | active | 2024-06 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.553 | Uveitis | active | 2024-06 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.554 | Post Cataract Surgery Cystoid Macular Edema AND Idiopathic Macular Edema | active | 2024-06 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.555 | Macular edema | active | 2024-06 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.556 | Corticosteroids for Injection | active | 2024-06 | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.557 | Corticosteroids for Injection | active | 2024-06 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.560 | Tonometry | active | 2024-06 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.561 | Intraocular pressure | active | 2024-06 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.571 | Retinal Vein Occlusion Related Macular Edema | active | 2024-06 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.576 | Vitreous hemorrhage | active | 2020-03 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.580 | Intravitreal and Periocular Injections | active | 2020-03 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.581 | Intravitreal and Periocular Injections | active | 2022-03 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.582 | Corticosteroids for Injection | active | 2020-03 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.583 | Endophthalmitis in the Right Eye | active | 2020-03 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.584 | Endophthalmitis in the Left Eye | active | 2020-03 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.585 | Panophthalmitis in the Right Eye | active | 2020-03 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.586 | Panophthalmitis in the Left Eye | active | 2020-03 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.587 | Lost to follow up | active | 2020-03 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.588 | Uveitis | active | 2020-03 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.610 | Scleral depressed exam | active | 2020-03 | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.611 | 3 Mirror Goldmann exam | active | 2020-03 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.612 | Scleral depressed exam | active | 2022-03 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.615 | Physical Disability | active | 2020-03 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.616 | Financial difficulty | active | 2020-03 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.617 | Vitreous exam findings | active | 2020-03 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.619 | Scleral depressed exam | active | 2020-03 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.629 | Post operative follow up | active | 2020-07 | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.67 | Breastfeeding | active | 2017-05 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.69 | Stable and Unstable Angina | active | 2025-02 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.70 | Ischemic Heart Disease or Related Diagnoses | active | 2021-02 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.71 | Cerebrovascular Disease Stroke or TIA | active | 2023-02 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.73 | Breastfeeding | active | 2021-02 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.85 | Familial Hypercholesterolemia | active | 2023-02 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.89 | Rhabdomyolysis | active | 2017-05 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.9 | Outpatient Encounters for Preventive Care | active | 2019-03 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.91 | Familial Hypercholesterolemia | active | 2021-02 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.93 | Hypercholesterolemia ICD 9 | active | 2024-06 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.97 | High Intensity Statin Therapy | active | 2024-02 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1047.98 | Moderate Intensity Statin Therapy | active | 2025-02 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1056.50 | HIV Lab Tests | active | 2025-02 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1056.51 | Indicators of Human Immunodeficiency Virus (HIV) | active | 2024-06 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1056.52 | Indicators of Human Immunodeficiency Virus (HIV) | active | 2024-06 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1056.53 | Indicators of Human Immunodeficiency Virus (HIV) | active | 2024-06 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1056.71 | Human Immunodeficiency Virus (HIV) Viral Load | active | 2024-06 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.10 | ARBs (Angiotensin Receptor Blockers) | active | 2024-12 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1000 | OIA_V2_GLP1s_RxNorms | active | 2025-02 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1001 | OIA_V2_PCSK9s_RxNorms | active | 2025-02 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1002 | OIA_RFs_Secondary_Prevention_ICD10 | active | 2025-02 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1003 | OIA_RFs_Secondary_Prevention_SNOMED | active | 2025-02 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1004 | OIA_RFs_Secondary_Prevention_CPT | active | 2025-02 | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1005 | OIA_RFs_Secondary_Prevention_ICD_SM_CPT | active | 2025-02 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1006 | OIA_Asthma_COPD_Combo_Meds | active | 2025-02 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1007 | OIA_Asthma_COPD_Combo_Meds_SABA_SAMA | active | 2025-02 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1008 | OIA_Asthma_COPD_Combo_Meds_LABA_LAMA_ICS | active | 2025-02 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1009 | PAE_Patient_Conditions | active | 2025-02 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1012 | PAE Conditions Short | active | 2025-02 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1016 | OIA_TEST_VS | active | 2025-03 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1017 | Triptan Allergy NDFRT | active | 2025-04 | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1018 | NSAID Allergy NDFRT | active | 2025-04 | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1019 | Statin Allergy NDFRT | active | 2025-04 | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1021 | Penicillin Allergy NDFRT | active | 2025-04 | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1022 | Macrolide Allergy NDFRT | active | 2025-04 | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1023 | Quinolone Allergy NDFRT | active | 2025-04 | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1025 | Beta blocker Allergy NDFRT | active | 2025-04 | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1026 | ACE inhibitor Allergy NDFRT | active | 2025-04 | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1027 | ARB Allergy NDFRT | active | 2025-04 | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1028 | Sulfonylurea Allergy NDFRT | active | 2025-04 | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1030 | DPP4i Allergy NDFRT | active | 2025-04 | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1031 | GLP1RA Allergy NDFRT | active | 2025-04 | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1032 | Beta blocker allergy intolerance | active | 2025-04 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1033 | SGLT2i Allergy NDFRT | active | 2025-04 | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1034 | MRA Allergy NDFRT | active | 2025-04 | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1036 | Meglitinide Allergy NDFRT | active | 2025-04 | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1037 | Alpha glucosidase inhibitor Allergy NDFRT | active | 2025-04 | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1038 | TZD Allergy NDFRT | active | 2025-04 | hl7 | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1041 | Hemoglobin | active | 2025-05 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1042 | Hematocrit | active | 2025-05 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1043 | Anemia for Erythropoesis Simulating Agents I10 | active | 2025-05 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1044 | Anemia for Erythropoesis Simulating Agents SCT | active | 2025-05 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1045 | Anemia for Erythropoesis Simulating Agents | active | 2025-05 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1046 | AZT Meds | active | 2025-05 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1047 | Ferritin | active | 2025-05 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1048 | Knee pain I10 | active | 2025-05 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1049 | Knee pain SCT | active | 2025-05 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.105 | conditions_heartfailure | active | 2023-07 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1050 | Knee pain | active | 2025-05 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1051 | Knee decreased ROM SCT | active | 2025-05 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1052 | Knee effusion I10 | active | 2025-05 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1054 | Knee effusion | active | 2025-05 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1055 | Knee crepitus SCT | active | 2025-05 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1056 | OIA_Antiemetics | active | 2025-05 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1057 | OIA_PDE5is | active | 2025-05 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1058 | OIA_Vitamins | active | 2025-05 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1059 | OIA_Plavix | active | 2025-05 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1061 | OIA_Oral_Contraceptives | active | 2025-05 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1063 | OIA_Topical_Steroids | active | 2025-05 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1064 | OIA_Cough_Cold_Meds | active | 2025-05 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1065 | Antiperspirant aluminum salts | active | 2025-05 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1066 | Antiperspirant anticholinergics | active | 2025-05 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1067 | Antieplieptic medications | active | 2025-05 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1068 | Antidepressant medications | active | 2025-05 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1069 | Urinary incontinence SCT | active | 2025-05 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1070 | Urinary incontinence I10 | active | 2025-05 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1071 | Urinary incontinence | active | 2025-05 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1073 | Hemifacial spasm SCT | active | 2025-05 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1074 | Hemifacial spasm I10 | active | 2025-05 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1075 | Hemifacial spasm | active | 2025-05 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1076 | Spasmodic dysphonia SCT | active | 2025-05 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1077 | Physical therapy procedure SCT | active | 2025-05 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1078 | Occupational therapy SCT | active | 2025-05 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1079 | Hyperhidrosis SCT | active | 2025-05 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1080 | Hyperhidrosis I10 | active | 2025-05 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1081 | Hyperhidrosis | active | 2025-05 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1082 | Tic disorder I10 | active | 2025-05 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1083 | Tic disorder SCT | active | 2025-05 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1084 | Tic disorder | active | 2025-05 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1085 | Esophageal achalasia SCT | active | 2025-05 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1086 | Esophageal achalasia I10 | active | 2025-05 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1087 | Esophageal achalasia | active | 2025-05 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1088 | ET propanolol or primidone | active | 2025-05 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1089 | ET topiramate alprazolam or gabapentin | active | 2025-05 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.109 | CKD stage4above I10 | active | 2024-05 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1090 | Blephraospasm SCT | active | 2025-05 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1091 | Blepharospasm I10 | active | 2025-05 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1092 | Blepharospasm | active | 2025-05 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1093 | Strabismus SCT | active | 2025-05 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1094 | Strabismus I10 | active | 2025-05 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1095 | Strabismus | active | 2025-05 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1096 | Overactive bladder SCT | active | 2025-05 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1097 | Overactive bladder I10 | active | 2025-05 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1098 | Overactive bladder | active | 2025-05 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1099 | Movement disorders SCT | active | 2025-05 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.110 | CKD stage4above SCT | active | 2024-06 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1100 | Movement disorders I10 | active | 2025-05 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1101 | Movement disorders | active | 2025-05 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1102 | Lateral epicondylitis SCT | active | 2025-05 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1103 | Lateral epicondyltisis I10 | active | 2025-05 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1104 | Lateral epicondylitis | active | 2025-05 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1105 | Plantar fasciitis SCT | active | 2025-05 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1106 | Plantar fasciitis I10 | active | 2025-05 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1107 | Plantar fasciitits | active | 2025-05 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1108 | Cardiac CT SCT | active | 2025-05 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1109 | Cardiac CT CPT | active | 2025-05 | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.111 | CKD stage4above | active | 2024-06 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1111 | Cardiac CT | active | 2025-05 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1112 | Cardiac MRI SCT | active | 2025-05 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1113 | Cardiac MRI CPT | active | 2025-05 | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1114 | Cardiac MRI | active | 2025-05 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1115 | CT Angiography of Coronary Artery SCT | active | 2025-05 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1116 | CT Angiography of Coronary Artery CPT | active | 2025-05 | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.1117 | CT Angiography of Coronary Artery | active | 2025-05 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.120 | Diabetic ketoacidosis SCT | active | 2023-07 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.121 | Diabetic ketoacidosis | active | 2023-07 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.146 | Long Acting Muscarinic Antagonists (LAMA) | active | 2023-11 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.159 | conditions_COPD I10 | active | 2024-08 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.175 | Asthma | active | 2025-05 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.184 | DigTx Virtual Reality Contraindications Visual Impairment | active | 2023-07 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.186 | Beta blockers GDMT for heart failure | active | 2023-12 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.188 | medications_heart failure | active | 2024-12 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.197 | Blood (Serum and Plasma) Potassium | active | 2023-11 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.214 | Type 1 Diabetes Mellitus SCT | active | 2023-07 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.238 | MRA mineralocorticoid receptor antagonists | active | 2024-10 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.244 | MRA Mineralocorticoid Receptor Antagonist Allergy | active | 2023-06 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.260 | UACR SCT | active | 2023-07 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.263 | Pregnancy I10 | active | 2023-11 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.281 | Statins Allergy SCT | active | 2023-03 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.282 | Statin Allergy Intolerance | active | 2025-04 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.314 | relatedconditions_hyperlipidemia I10 | active | 2023-10 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.337 | Migraine I10 | active | 2023-03 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.34 | Blood pressure panel | active | 2024-04 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.35 | Systolic Blood Pressure | active | 2024-04 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.367 | Trandolapril | active | 2024-12 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.369 | Candesartan | active | 2023-07 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.377 | Valsartan | active | 2023-07 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.397 | eGFR | active | 2025-03 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.412 | Statin Moderate Intensity | active | 2024-08 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.415 | LDL Cholesterol | active | 2024-02 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.43 | Urinalysis | active | 2024-02 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.434 | Insulin | active | 2025-02 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.437 | TZD Thiazolidinediones | active | 2025-05 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.438 | medications_T2DM | active | 2023-08 | hl7 | vsac |